Pfizer may soon play pharmaceutical musical chairs by relocating some of its overseas drug production back to the U.S., responding to the tariff tango initiated by President Trump. Pfizer CEO Albert ...

In mid-March here, I (Tom Yeung) wrote about three stocks to sell on an escalating trade war. President Donald Trump was ratcheting his tariff rhetoric, so we highlighted three import-reliant firms to ...

Read on to learn why. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks. Make smarter investments with weekly expert stock picks from the ...

Try not to let market volatility bring you down. Instead, let dividend stocks make you happy. These high-yield dividend ...

If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly.

Moores Cancer Center at the University of California San Diego has received a $1 million donation from pharmaceutical company ...

Sangamo, which has been having cash problems, will receive $18 million upfront in licensing fees for its AAV capsid that in ...

As the respiratory syncytial virus (RSV) vaccine field grapples with a significantly reduced market size thanks to regulatory ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the new Donald Trump administration. Health care stocks can often be a solid defensive play in an uncertain economy.

We recently published a list of 11 Best Innovative Stocks to Buy According to Analysts. In this article, we are going to take a look at where Pfizer Inc.

British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory ...